MarketPeel
Insider Trading Intelligence
GB

Gabriel Brooks

SLDB
CHIEF MEDICAL OFFICER · SOLID BIOSCIENCES INC. · CIK 0001997809
FILING MIX · LIFETIME57%/43%
BUYS
16
SELLS
12
TOTAL VALUE
$312.8K
COMPANIES
1
ACTIVE SINCE
Oct 2023
HOLDINGS NOW
89,466
AVG SELL PX
$6.25
TRADE KIND
SHOWING 28 / 28
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
6 backtested trades · 8 horizons · 13 pending
Forward-return performance of every backtestable P/S trade by Gabriel Brooks, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d6+33.33%+8.49%+0.27%+8.22%+3.12%
14d6+66.67%+0.09%-0.85%+0.94%-4.80%
30d6+50.00%+1.47%-2.68%+4.15%+1.25%
60d6+50.00%+2.28%-2.49%+4.77%+8.69%
90d6+50.00%-10.66%+3.30%-13.96%-6.95%
180d6(3 pending)+33.33%+16.63%+0.88%+15.75%+34.54%
1y6(4 pending)+0.00%+28.43%+13.95%+14.48%+14.48%
2y6(6 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SLDB · 89,466 shares · as of Feb 18, 2026
051,863103,725155,588207,450202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 16 buys / 12 sellsCOVERAGE · 10 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SLDB
SOLID BIOSCIENCES INC.
SALE10b5-1
10b5-1 plan
0$5.8289,466Feb 18, 2026Feb 18, 2026View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
Chief Medical Officer
10,93795,029Feb 13, 2026Feb 18, 2026View →
SLDB
SOLID BIOSCIENCES INC.
SALE
Chief Medical Officer
10,93721,876Feb 13, 2026Feb 18, 2026View →
SLDB
SOLID BIOSCIENCES INC.
SALE10b5-1
10b5-1 plan
12,616$6.44$81.3K84,092Feb 4, 2026Feb 6, 2026View →
SLDB
SOLID BIOSCIENCES INC.
SALE10b5-1
10b5-1 plan
28,335$6.44$182.4K96,708Feb 2, 2026Feb 2, 2026View →
SLDB
SOLID BIOSCIENCES INC.
SALE
Chief Medical Officer
28,22584,675Jan 31, 2026Feb 2, 2026View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
Chief Medical Officer
28,225125,043Jan 31, 2026Feb 2, 2026View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
103,750103,750Jan 29, 2026Feb 2, 2026View →
SLDB
SOLID BIOSCIENCES INC.
SALE
Chief Medical Officer
58,8470Jan 29, 2026Feb 2, 2026View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
207,450207,450Jan 29, 2026Feb 2, 2026View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
Chief Medical Officer
58,84796,818Jan 29, 2026Feb 2, 2026View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
58,84758,847Jan 29, 2026Apr 21, 2026View →
SLDB
SOLID BIOSCIENCES INC.
SALE
Chief Medical Officer
2,895$5.96$17.3K33,819Oct 20, 2025Oct 21, 2025View →
SLDB
SOLID BIOSCIENCES INC.
SALE
Chief Medical Officer
9,75019,500Oct 18, 2025Oct 21, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
Chief Medical Officer
9,75036,714Oct 18, 2025Oct 21, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
71,25071,250Aug 14, 2025Aug 18, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
142,500142,500Aug 14, 2025Aug 18, 2025View →
SLDB
SOLID BIOSCIENCES INC.
SALE10b5-1
10b5-1 plan
3,256$3.96$12.9K22,812Feb 14, 2025Feb 18, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
Chief Medical Officer
10,93726,068Feb 13, 2025Feb 18, 2025View →
SLDB
SOLID BIOSCIENCES INC.
SALE
Chief Medical Officer
10,93732,813Feb 13, 2025Feb 18, 2025View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
112,900112,900Jan 31, 2025Feb 11, 2025View →
SLDB
SOLID BIOSCIENCES INC.
SALE
Chief Medical Officer
2,923$6.50$19.0K10,979Oct 21, 2024Oct 22, 2024View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASE
Chief Medical Officer
9,75013,902Oct 18, 2024Oct 22, 2024View →
SLDB
SOLID BIOSCIENCES INC.
SALE
Chief Medical Officer
9,75029,250Oct 18, 2024Oct 22, 2024View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
43,75043,750Feb 13, 2024Feb 16, 2024View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
87,50087,500Feb 13, 2024Feb 16, 2024View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
39,00039,000Oct 18, 2023Oct 20, 2023View →
SLDB
SOLID BIOSCIENCES INC.
PURCHASEGRANT
Stock grant
78,00078,000Oct 18, 2023Oct 20, 2023View →
Other insiders · SLDB
Loading peer insiders…
About this filer
CIK 0001997809
ROLE
Chief Medical Officer
PRIMARY
SLDB
COMPANIES
1
ACTIVE SINCE
Oct 2023
MARKETPEEL · /INSIDER/0001997809DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback